During the past decade, Singapore eye research institute conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 2 clinical trials were completed, i.e. on average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Singapore eye research institute" #1 sponsor was "Singapore National Eye Centre" with 20 trials, followed by "Singapore Eye Research Institute" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Asia Cornea Society" with 1 trials sponsored and "Johnson & Johnson Surgical Vision, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Singapore eye research institute" #1 collaborator was "National Medical Research Council (NMRC), Singapore" with 3 trials as a collaborator, "NeuroVision" with 3 trials as a collaborator, "Chugai Pharmaceutical" with 2 trials as a collaborator, "Singapore Eye Research Institute" with 2 trials as a collaborator and "Defence Medical Environmental Research Institute" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Singapore eye research institute" are "Dry Eye" (7 trials), "Myopia" (7 trials), "Dry Eyes" (4 trials), "Diabetic Macular Edema" (2 trials) and "Glaucoma" (2 trials). Many other conditions were trialed in "Singapore eye research institute" in a lesser frequency.

Most popular intervention types in "Singapore eye research institute" are "Drug" (12 trials), "Procedure" (12 trials), "Device" (11 trials), "Other" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Neurovision" (2 trials) and "0.1% sodium hyaluronate ophthalmic solution." (1 trials). Other intervention names were less common.

The vast majority of trials in "Singapore eye research institute" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Singapore eye research institute". 1 are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Singapore eye research institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Singapore eye research institute, 4 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 16 trials that are defined as “Not Applicable".